Moonwalk Biosciences, Inc.
Biotechnology

Moonwalk Biosciences, Inc. news and milestones

Moonwalk Biosciences, Inc.: 14 headlines on record, 7 headlines in the last 90 days. Its story counts 3 milestones.

Data updated Nov 17, 2026 · Back to the company report
14Headlines
7In 90 days
3Milestones

Headlines

Sep 282026
News · pharmexec.com
Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platfor…
Sep 212026
News · RFWrightLSL
On this weeks episode of the Business of Biotech, Alex Aravanis, M.D., Ph.D., CEO of Moonwalk Biosciences, talks about the opportunity in obesity beyond GLP-1s.
Sep 92026
News · YahooFinance
The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today
Sep 82026
News · Pulse 2.0
Moonwalk Biosciences has raised an oversubscribed $70 million Series B financing to advance its pipeline of adipose-targeted RNA interference medicines for obesity and cardiometa…
Sep 82026
News · YahooFinance
SOUTH SAN FRANCISCO & SAN DIEGO, September 08, 2026--Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Card…
Jan 5, 20242024
News · Pulse 2.0
Moonwalk Biosciences - a genomic medicine company pioneering precision epigenetic medicines - recently announced the completion of $57 million in seed and Series A financing from…
Jan 4, 20242024
Jan 4, 20242024
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Moonwalk Biosciences, Inc., News. Alion, Nov 17, 2026. https://alion.io/company/moonwalk/news

.json · .md · CC BY-SA 4.0